How long does it take to stop taking sotoracib (AMG510)?

Sotorasib (AMG510, Sotorasib) is a targeted drug for the treatment of specific types of lung cancer. It is mainly used to treat adult patients with locally advanced (not suitable for curative treatment) or metastatic non-small cell lung cancer with KRAS G12C mutations who have received at least 1 previous systemic therapy. The timing of its use and treatment schedule need to be determined based on the patient's specific situation and the doctor's recommendations. During treatment with sotoracib, patients should strictly follow the doctor's instructions in using the medication and should not stop taking the medication or change the medication pattern on their own.

Sotoraxib is a highly selective inhibitor of KRAS G12C, which inhibits the rapid proliferation of cancer cells. It is available as oral tablets, with the recommended dose in the product monograph being 960 mg (8 x 120 mg tablets) taken orally once daily until disease progression or unacceptable toxicity. While taking sotoracib, patients usually need to conduct regular follow-up and examinations according to the guidance of their doctors to assess the size, location, number of tumors, and the patient's physical condition. Doctors will use these assessment results to determine the effectiveness of the treatment and adjust the treatment plan accordingly, including whether to continue taking or discontinue medication.

Generally speaking, if the patient's condition is under stable control after taking sotorasib, the tumor has not progressed significantly, and the patient can tolerate the side effects of the drug, then the doctor may recommend that the patient continue to take the drug to maintain the therapeutic effect. However, if a patient's tumor progresses or they experience serious drug side effects, doctors may consider stopping the drug and trying other treatment options.

In addition, the withdrawal time of sotoracib may also be affected by various factors such as individual patient differences, drug dosage, and medication methods. Therefore, while taking sotorasiib, patients need to pay close attention to their physical condition and communicate with their doctors in a timely manner so that doctors can adjust the treatment plan in a timely manner to ensure patient safety and therapeutic effects.